+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Continuous Manufacturing Market Research Report by Application, by Distribution, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968719
  • Report
  • July 2021
  • Region: Global
  • 186 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Pharmaceutical Continuous Manufacturing Market will Grow to USD 956.06 Million by 2026, at a CAGR of 12.64%

FEATURED COMPANIES

  • 3P Biopharmaceuticals
  • ABN Cleanroom Technology
  • Bayer AG
  • Coperion GmbH
  • GEA
  • Johnson & Johnson’s,
  • MORE
The Global Pharmaceutical Continuous Manufacturing Market size was estimated at USD 467.86 Million in 2020 and expected to reach USD 527.32 Million in 2021, at a Compound Annual Growth Rate (CAGR) 12.64% to reach USD 956.06 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pharmaceutical Continuous Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Pharmaceutical Continuous Manufacturing Market was examined across Active Pharmaceutical Ingredient, Biologics, and Dry Powders.
  • Based on End User, the Pharmaceutical Continuous Manufacturing Market was examined across Contract Manufacturing Organization and Pharmaceutical Companies.
  • Based on Distribution, the Pharmaceutical Continuous Manufacturing Market was examined across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Geography, the Pharmaceutical Continuous Manufacturing Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Continuous Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Continuous Manufacturing Market, including 3P Biopharmaceuticals, Abbott, AbbVie Inc., ABN Cleanroom Technology, AC Immune, Baker Perkins Ltd, Bayer AG, Bosch Packaging Technology, Chemtrix, Continuous Pharmaceutical, Coperion GmbH, Corning Life Sciences, Eli Lilly and Company, GEA, Gebrüder Lödige Maschinenbau GmbH, Genzyme Corporation, Glatt GmbH, Hosokawa Micron Corporation, Janssen Global Services, LLC, Johnson & Johnson’s,, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Novartis AG, S K Biotek Ltd, Scott Equipment Company, Siemens AG, Sturtevant, Inc, Syntegon Technology GmbH, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Continuous Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Continuous Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Continuous Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Continuous Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Continuous Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Continuous Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Continuous Manufacturing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3P Biopharmaceuticals
  • ABN Cleanroom Technology
  • Bayer AG
  • Coperion GmbH
  • GEA
  • Johnson & Johnson’s,
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. End User Outlook
3.5. Distribution Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential demand attributed to cost-effective approach
5.1.1.2. Favorable regulatory policies for adoption of continuous manufacturing systems
5.1.1.3. Increasing application owing to better efficiency of manufacturing operations
5.1.2. Restraints
5.1.2.1. Dearth of technical and regulatory clarities
5.1.3. Opportunities
5.1.3.1. Emerging collaborations between industry and academics
5.1.3.2. Ongoing growth in generic manufacturing
5.1.4. Challenges
5.1.4.1. High infrastructural investments and concerns regarding cleaning validation
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Pharmaceutical Continuous Manufacturing Market, by Application
6.1. Introduction
6.2. Active Pharmaceutical Ingredient
6.3. Biologics
6.4. Dry Powders

7. Pharmaceutical Continuous Manufacturing Market, by End User
7.1. Introduction
7.2. Contract Manufacturing Organization
7.3. Pharmaceutical Companies

8. Pharmaceutical Continuous Manufacturing Market, by Distribution
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy

9. Americas Pharmaceutical Continuous Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Pharmaceutical Continuous Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Pharmaceutical Continuous Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 3P Biopharmaceuticals
13.2. Abbott
13.3. AbbVie Inc.
13.4. ABN Cleanroom Technology
13.5. AC Immune
13.6. Baker Perkins Ltd
13.7. Bayer AG
13.8. Bosch Packaging Technology
13.9. Chemtrix
13.10. Continuous Pharmaceutical
13.11. Coperion GmbH
13.12. Corning Life Sciences
13.13. Eli Lilly and Company
13.14. GEA
13.15. Gebrüder Lödige Maschinenbau GmbH
13.16. Genzyme Corporation
13.17. Glatt GmbH
13.18. Hosokawa Micron Corporation
13.19. Janssen Global Services, LLC
13.20. Johnson & Johnson’s,
13.21. Korsch AG
13.22. L.B. Bohle Maschinen + Verfahren GmbH
13.23. Novartis AG
13.24. S K Biotek Ltd
13.25. Scott Equipment Company
13.26. Siemens AG
13.27. Sturtevant, Inc
13.28. Syntegon Technology GmbH
13.29. Thermo Fisher Scientific Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2020 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2026
FIGURE 12. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2026
FIGURE 21. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (%)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2026
FIGURE 28. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 34. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 35. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 37. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 38. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 39. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 40. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 41. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 42. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 43. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 45. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 46. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 47. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 48. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 49. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 50. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 51. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 52. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 53. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 54. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 58. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 61. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 62. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 63. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: FPNV POSITIONING MATRIX
FIGURE 70. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 17. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 18. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 19. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 20. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 21. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 22. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 23. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 24. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 25. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 26. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 27. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 28. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 29. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 30. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 33. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 34. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 35. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 36. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 37. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 39. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 40. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 41. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 42. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 43. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 44. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 45. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 46. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 47. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 48. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 49. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 50. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 51. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 52. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 53. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 54. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 55. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 56. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 57. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 58. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 59. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 60. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 61. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 62. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 63. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 64. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 65. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 66. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 67. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 68. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 73. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 74. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 75. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 76. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 77. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 78. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 79. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 80. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 81. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 82. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 83. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 84. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 85. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 86. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 87. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 88. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 89. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 90. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 91. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 92. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 93. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 94. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 95. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 96. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 97. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 98. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 99. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 101. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 102. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 103. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 104. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 105. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2018-2026 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: SCORES
TABLE 107. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 108. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 109. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: RANKING
TABLE 110. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 111. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 112. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 113. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 114. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 115. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 116. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 3P Biopharmaceuticals
  • Abbott
  • AbbVie Inc.
  • ABN Cleanroom Technology
  • AC Immune
  • Baker Perkins Ltd
  • Bayer AG
  • Bosch Packaging Technology
  • Chemtrix
  • Continuous Pharmaceutical
  • Coperion GmbH
  • Corning Life Sciences
  • Eli Lilly and Company
  • GEA
  • Gebrüder Lödige Maschinenbau GmbH
  • Genzyme Corporation
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Janssen Global Services, LLC
  • Johnson & Johnson’s,
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Novartis AG
  • S K Biotek Ltd
  • Scott Equipment Company
  • Siemens AG
  • Sturtevant, Inc
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll